Ms. Thompson and I are pleased to appear here before you to discuss issues related to the opiate substitution program for the offender population within the Correctional Service of Canada. The commissioner, Mr. Don Head, and the assistant commissioner of health services, Ms. Leslie MacLean, appeared before you in June 2009 and provided with you with information about the mental health strategies and initiatives within CSC. Today we will brief you on the CSC's opiate substitution program.
Injection drug use, primarily the practice of sharing injection equipment, is a major risk in the transmission of infectious diseases such as HIV and hepatitis C. Substance abuse is also a factor contributing to the commission of many crimes. Providing an opiate substitution treatment program to federal offenders helps to reduce the demand for drugs, thus improving our ability to contribute to public safety.
Research has shown that active participation in opiate substitution therapy is associated with positive release outcomes for offenders. Johnson et al. (2001) found that offenders who had participated in a methadone maintenance treatment program while incarcerated were 28% less likely to be returned to custody after release to the community than offenders who had not.
l'II provide you with the background on the program. Originally called the national methadone maintenance treatment program, it was implemented in two phases. In 1997, phase one allowed opiate-addicted offenders who were in a community methadone program prior to being sentenced to be considered for continuation of methadone treatment. Phase two, announced in May 2002, increased CSC's capacity to initiate treatment of opiate-addicted offenders requesting methadone if such treatment was deemed medically appropriate.
In December 2008 the methadone program was renamed the national opiate substitution treatment program because of the addition of an alternative opiate substitute medication called Suboxone.
When used in conjunction with cognitive programming, intensive monitoring, and support, opiate substitution has been found to be extremely helpful for opiate-dependent persons. These medications can help free the opiate-dependent person from the continuous cycle of withdrawal and opiate use. Stabilization on opiate substitutes allows offenders to concentrate in school and participate in programming and work, thus increasing their ability to actively engage in their correctional plan.
Prior to initiation of treatment, a detailed health and mental health assessment is conducted with each offender to determine whether the offender meets the necessary criteria, such as whether the offender has received from a physician a diagnosis of dependency to opiates. Congruent with community practice, the assessment process includes a review of the rules of the program outlined in a treatment agreement between the offender and care providers, outlining what each commits to, including the requirement for ongoing monitoring.
In 2009-10 the cost of CSC's opiate substitution program was over $12 million. As of January 2010, there were 701 offenders on opiate substitution therapy across the country, of whom 55 were women offenders. Due to offender flow-through, over 1,000 offenders are managed on the program by CSC every year. CSC's opiate substitution program is managed in a multi-disciplinary team approach, with involvement from case management, programs, and health services, and in accordance with national guidelines.
In 2009, of the 512 offenders who were admitted to the CSC opiate substitution program from the community, most were received from provincial correctional facilities. The majority of these facilities provide treatment to offenders who are already on methadone in the community. For those offenders entering CSC already on methadone, CSC maintains their treatment while they undergo assessment to ensure they meet the program criteria.
To ensure safety and security, offenders are observed for 20 minutes after taking their methadone, which reduces the risk that offenders will divert the medications. A nurse provides each dose directly to the offender and watches the offender swallow the medication. The offenders are observed for 20 minutes to ensure that most of the medication is absorbed.
All offenders in treatment are expected to participate in regular substance abuse programs, which are specifically geared to opiate dependence and delivered by trained program delivery officers. An offender's progress is monitored and reviewed on a regular basis through meetings with their individualized intervention team.
The opiate substitution program is subject to regular medical and institutional reviews to provide early identification of areas of concern, tailor educational training sessions for staff, and modify procedural policies.
Extensive preparation is done for any offender being released to the community on opiate substitution to ensure the transition is smooth and continuity of care is maintained. This process starts at the onset of initiation into the program. The availability of a community provider is reviewed and confirmed six months prior to release.
Thank you.